Summary of AMICUS THERAPEUTICS INC

Item 8.01. Other Events.

During the first quarter of 2012, Amicus Therapeutics, Inc. (the "Company") adopted an accounting standard which eliminated the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity, which was the presentation used in the Company's 2011 Annual Report on Form 10-K. The adopted accounting standard requires the presentation of the components of net income, other comprehensive income and total comprehensive income in either one continuous statement or two separate consecutive statements. The components of other comprehensive (loss) income and total comprehensive loss for the years ended December 31, 2009, 2010 and 2011 and the period from February 4, 2002 (inception) to December 31, 2011 are presented below (in thousands):

                                                                             Period from
                                                                             February 4,
                                                                                 2002
                                                                            (Inception) to
                                        Year Ended December 31,              December 31,
                                  2009           2010           2011             2011
Net loss                       $    (6,567 )  $   (54,936 )  $   (44,412 )        (270,104 )
Unrealized (loss) gain on
short-term investments                (490 )          (71 )           32                 4
Total comprehensive loss       $    (7,057 )  $   (55,007 )  $   (44,380 )        (270,100 )